Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that has transformed metabolic disease treatment
Ozempic (semaglutide 0.25mg, 0.5mg, 1mg, 2mg) is MHRA-licensed for type 2 diabetes, and Wegovy (semaglutide 2.4mg) is the only MHRA-licensed semaglutide weight-management medicine in the UK as of 2026 [1][13][14]
Warnings and Precautions 5.1 Never Share a TRESIBA FlexTouch Pen, Needle, or Insulin Syringe Between Patients TRESIBA FlexTouch disposable prefilled pens should never be shared between patients, even if the needle is changed
Understanding the broader context of weight loss can empower individuals to choose the best method for their lifestyle and health goals
US$ 29.33
US$ 25.43
US$ 20.18
US$ 21.17
US$ 26.50
